Arcutis Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Arcutis Biotherapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. 

CEO
Todd Franklin Watanabe
CEOTodd Franklin Watanabe
Employees
354
Employees354
Headquarters
Westlake Village, California
HeadquartersWestlake Village, California
Founded
2016
Founded2016
Employees
354
Employees354

ARQT Key Statistics

Market cap
3.60B
Market cap3.60B
Price-Earnings ratio
127.52
Price-Earnings ratio127.52
Dividend yield
—
Dividend yield—
Average volume
2.18M
Average volume2.18M
High today
$29.31
High today$29.31
Low today
$28.44
Low today$28.44
Open price
$29.13
Open price$29.13
Volume
281.55K
Volume281.55K
52 Week high
$31.77
52 Week high$31.77
52 Week low
$19.30
52 Week low$19.30

Stock Snapshot

As of today, Arcutis Biotherapeutics(ARQT) shares are valued at $28.63. The company's market cap stands at 3.6B, with a P/E ratio of 127.52.

On 2026-10-16, Arcutis Biotherapeutics(ARQT) stock traded between a low of $28.44 and a high of $29.31. Shares are currently priced at $28.63, which is +0.7% above the low and -2.3% below the high.

Arcutis Biotherapeutics(ARQT) shares are trading with a volume of 281.55K, against a daily average of 2.18M.

In the last year, Arcutis Biotherapeutics(ARQT) shares hit a 52-week high of $31.77 and a 52-week low of $19.30.

In the last year, Arcutis Biotherapeutics(ARQT) shares hit a 52-week high of $31.77 and a 52-week low of $19.30.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ARQT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.